ctrl K

Watchlist Price Alert

Cadrenal Therapeutics Inc... (CVKD)

NASDAQ: CVKD · Real-Time Price · USD

10.50

0.22 (2.14%)

At close: Jun 27, 2025, 11:13 AM

Cadrenal Therapeutics Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	n/a	n/a	n/a
Cost of Revenue	1.88K	1.98K	1.27K
Gross Profit	n/a	-1.98K	-1.27K
Operating Income	-10.96M	-7.63M	-2.7M
Interest Income	n/a	249.09K	n/a
Pretax Income	-10.65M	-8.36M	-6.71M
Net Income	-10.65M	-8.36M	-6.71M
Selling & General & Admin	6.75M	3.55M	2.31M
Research & Development	4.21M	4.08M	392.86K
Other Expenses	1.88K	n/a	n/a
Operating Expenses	10.96M	7.63M	2.7M
Interest Expense	n/a	17.1K	107.11K
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	n/a	7.63M	2.7M
Income Tax Expense	n/a	n/a	4.00
Shares Outstanding (Basic)	1.22M	868.18K	775.64K
Shares Outstanding (Diluted)	1.22M	868.18K	775.64K
EPS (Basic)	-8.73	-9.63	-8.66
EPS (Diluted)	-8.73	-9.63	-8.66
EBITDA	-10.65M	-8.34M	-6.61M
EBIT	-10.65M	-8.34M	-6.61M
Depreciation & Amortization	1.88K	1.98K	1.27K